scispace - formally typeset
G

Gary L. Euler

Researcher at National Center for Immunization and Respiratory Diseases

Publications -  43
Citations -  3905

Gary L. Euler is an academic researcher from National Center for Immunization and Respiratory Diseases. The author has contributed to research in topics: Vaccination & Population. The author has an hindex of 27, co-authored 43 publications receiving 3774 citations. Previous affiliations of Gary L. Euler include Centers for Disease Control and Prevention.

Papers
More filters
Journal Article

Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.

TL;DR: This report updates the 2008 recommendations by CDC's Advisory Committee on Immunization Practices regarding the use of influenza vaccine for the prevention and control of seasonal influenza and includes a summary of safety data for U.S. licensed influenza vaccines.
Journal ArticleDOI

Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors?

TL;DR: Variation was found across vaccines, however, sensitivity and specificity did not vary substantially by either age or race/ethnicity; Hispanics were 2.7 times more likely to claim receipt of vaccination compared to whites.
Journal ArticleDOI

Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007

TL;DR: Awareness of HPV and HPV vaccine were high and one in ten women 18-26 years old had initiated the HPV vaccine series two to 5 months after national HPV vaccination recommendations were published.
Journal ArticleDOI

Influenza vaccination of recommended adult populations, U.S., 1989–2005 ☆

TL;DR: A concerted effort to increase provider adoption of standards for adult immunization, public awareness, and stable vaccine supplies is needed to improve influenza vaccination rates among recommended groups, and to reduce racial and ethnic disparities.
Journal Article

Interim results: influenza A (H1N1) 2009 monovalent vaccination coverage - United States, October-December 2009.

TL;DR: Now that an ample supply of 2009 H1N1 vaccine is available, efforts should continue to increase vaccination coverage among persons in the initial target groups and to offer vaccination to the rest of the U.S. population, including those aged >or=65 years.